Stockscreener 앱 받기
8.93
6.95%
0.58
시간 외 거래:
8.96
0.03
+0.34%
전일 마감가:
$8.35
열려 있는:
$8.76
하루 거래량:
392.43K
Relative Volume:
2.59
시가총액:
$96.69M
수익:
$1.93M
순이익/손실:
$-7.96M
주가수익비율:
-0.00253
EPS:
-3530.8178
순현금흐름:
$-36.78M
1주 성능:
+13.18%
1개월 성능:
+84.12%
6개월 성능:
+9.17%
1년 성능:
-22.11%
1일 변동 폭
$8.37
$9.25
1주일 범위
$7.87
$9.4099
52주 변동 폭
$3.39
$16.00
아발로 테라퓨틱스 Stock (AVTX) Company Profile
명칭
Avalo Therapeutics Inc
전화
410-522-8707
주소
1500 LIBERTY RIDGE DRIVE, WAYNE
AVTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
8.93 | 89.98M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
아발로 테라퓨틱스 Stock (AVTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | H.C. Wainwright | Buy |
| 2025-03-25 | 개시 | Jefferies | Buy |
| 2025-03-25 | 개시 | Stifel | Buy |
| 2025-02-28 | 개시 | Piper Sandler | Overweight |
| 2025-02-21 | 개시 | Wedbush | Outperform |
| 2024-12-19 | 개시 | BTIG Research | Buy |
| 2024-10-24 | 개시 | H.C. Wainwright | Neutral |
| 2024-04-16 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-09-24 | 개시 | RBC Capital Mkts | Outperform |
모두보기
아발로 테라퓨틱스 주식(AVTX)의 최신 뉴스
Avalo Therapeutics Inc. stock chart pattern explainedPortfolio Positioning Strategy With Timing - Newser
Avalo Therapeutics Reports Q2 2025 Financial Results - TipRanks
Is Avalo Therapeutics Inc. reversing from oversold territoryChart Driven Opportunity Scanner with Alerts - Newser
Can Avalo Therapeutics Inc. recover in the next quarterFree Trade Timing Strategy With Technical Data - Newser
How to track smart money flows in Avalo Therapeutics Inc.Safe Entry Strategy with High Win Rate - Newser
Will a bounce in Avalo Therapeutics Inc. offer an exitReal-Time Entry Signals for Top Stocks - Newser
Using RSI to spot recovery in Avalo Therapeutics Inc.High Return Strategy with Low Risk - Newser
What institutions are buying Avalo Therapeutics Inc. stock nowFree Oversold Bounce Stock Play Ideas - Newser
How to forecast Avalo Therapeutics Inc. trends using time seriesFree Intraday Trend Analysis for Fast Gains - Newser
Risk vs reward if holding onto Avalo Therapeutics Inc.Buy Point Strategy with Profit Protection - Newser
Custom strategy builders for tracking Avalo Therapeutics Inc.Daily Upside Movement Prediction With Data - Newser
Can swing trading help recover from Avalo Therapeutics Inc. lossesLong Term Stock Planner with Safety Checks - Newser
Pattern recognition hints at Avalo Therapeutics Inc. upsideFree AI Screening for Swing Trade Picks - Newser
Buy Signal for Avalo Therapeutics Inc. Stock Key Technical Indicators to WatchIntraday Signal Forecast for Fast Traders - Newser
Avalo Therapeutics: Promising Phase 2 Trial and Market Opportunities Drive Buy Rating - TipRanks
Does Avalo Therapeutics Inc. stock pay reliable dividendsPrice Forecast Based on AI Analysis - Newser
What momentum shifts mean for Avalo Therapeutics Inc.AI Volatility Forecast and Risk Monitor - Newser
Avalo Reports Second Quarter 2025 Financial Results and Recent Business Updates - GlobeNewswire
Is Avalo Therapeutics Inc. forming a reversal patternHistorical Market Behavior and Trend Summary - Newser
Risk adjusted return profile for Avalo Therapeutics Inc. analyzedFree Real-Time Market Sentiment Tracking Tool - Newser
Why Avalo Therapeutics Inc. stock attracts strong analyst attentionReliable Setup Screener with Low Risk - Newser
Chart based exit strategy for Avalo Therapeutics Inc.AI Screener Based Stock Summary Report - Newser
Avalo Therapeutics (AVTX) up more than 100% since Jul 11 - AInvest
Is Avalo Therapeutics Inc. still worth holding after the dipWeekly Chart Watchlist with Trade Guidance - Newser
How does Avalo Therapeutics Inc. generate profit in a changing economyCapitalize on proven trading setups - Jammu Links News
How does Avalo Therapeutics Inc. compare to its industry peersConsistently exceptional gains - Jammu Links News
What makes Avalo Therapeutics Inc. stock price move sharplyMaximize portfolio value with smart investment plans - Jammu Links News
Is Avalo Therapeutics Inc. a good long term investmentConsistently exceptional gains - Jammu Links News
Why is Avalo Therapeutics Inc. stock attracting strong analyst attentionCapitalize on emerging industry trends - Jammu Links News
Developing predictive dashboards with Avalo Therapeutics Inc. dataPortfolio Booster Strategy with Trend Confidence - newser.com
아발로 테라퓨틱스 (AVTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):